[Comparative effectiveness and tolerance in the vanquin, combantrin and vermox treatments of enterobiasis].
D001562:Benzimidazoles / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008463:Mebendazole / Q000627:therapeutic use*; D010123:Oxyuriasis / Q000188:drug therapy*; D011715:Pyrantel / Q000031:analogs & derivatives*; D011716:Pyrantel Pamoate / Q000627:therapeutic use*; D011774:Pyrvinium Compounds / Q000627:therapeutic use*; D013997:Time Factors
D001562:Benzimidazoles; D011774:Pyrvinium Compounds; D011715:Pyrantel; C024631:pyrvinium; D011716:Pyrantel Pamoate; D008463:Mebendazole
Sravnitel'naia éffektivnost' i perenosimost' lecheniia énterobioza vankinom, kombantrinom i vermoksom.